Preventive therapy in children exposed to Mycobacterium tuberculosis: problems and solutions (Q26851747)

Mycobacterium tuberculosis

main subject

0 references

5

Reinout van Crevel

0 references

Rina Triasih

object named as

Rina Triasih

3

0 references

Merrin E. Rutherford

1

object named as

Merrin E. Rutherford

1 reference

Philip C. Hill

2

1 reference

Rebecca Sinfield

4

1 reference

Stephen M. Graham

6

1 reference

language of work or name

1 reference

October 2012

1 reference

Tropical Medicine and International Health

published in

1 reference

volume

17

1 reference

issue

10

1 reference

page(s)

1264-73

1 reference

Compliance with anti-tuberculosis preventive therapy among 6-year-old children

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Isoniazid preventive therapy and risk for resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

An algorithm for tuberculosis screening and diagnosis in people with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Cost-effectiveness of isoniazid chemoprevention in close contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Opportunities for chemoprophylaxis in children with culture-confirmed tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Eliminating human tuberculosis in the twenty-first century

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Latent tuberculosis infection in children: a call for revised treatment guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Toxicity of first-line drugs for treatment of tuberculosis in children: review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Impact of tuberculosis exposure at home on mortality in children under 5 years of age in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Symptom screening among HIV-infected pregnant women is acceptable and has high negative predictive value for active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Modelling the efficacy of prophylactic and curative therapies for preventing the spread of tuberculosis in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Closing the policy-practice gap in the management of child contacts of tuberculosis cases in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Routine checks for HIV in children attending primary health care facilities in South Africa: attitudes of nurses and child caregivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Symptom-based screening of child tuberculosis contacts: improved feasibility in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Radiographic signs and symptoms in children treated for tuberculosis: possible implications for symptom-based screening in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Adherence to isoniazid preventive chemotherapy: a prospective community based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Diagnostic and management challenges for childhood tuberculosis in the era of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Screening and preventive therapy for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Frequency and type of reactions to antituberculosis drugs: observations in routine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Use of intermittent rifampin and pyrazinamide therapy for latent tuberculosis infection in a targeted tuberculin testing program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Childhood tuberculosis - global epidemiology and the impact of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

QuantiFERON®-TB Gold In-Tube assay vs. tuberculin skin test in Indonesian children living with a tuberculosis case

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Risk factors for TB infection and disease in young childhood contacts in Malawi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Isoniazid liver injury during chemoprophylaxis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Three months of rifapentine and isoniazid for latent tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

Contact investigation of children exposed to tuberculosis in South East Asia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

7 January 2021

Evaluation of the efficacy of health education on the compliance with antituberculosis chemoprophylaxis in school children. A randomized clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

7 January 2021

Should primary tuberculosis in children continue to be neglected?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

7 January 2021

Safety and completion rate of short-course therapy for treatment of latent tuberculosis infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

7 January 2021

The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

7 January 2021

Short course chemotherapy for tuberculosis in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

7 January 2021

Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

7 January 2021

Expanding tuberculosis case detection by screening household contacts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

7 January 2021

Patient choice promotes adherence in preventive treatment for latent tuberculosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03053.X

7 January 2021